BIOMARIN PHARMACEUTICAL INC Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, shares, employee stock purchase plans for the quarter ending 2019-09-30 was 0.00 shares.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, shares, employee stock purchase plans for the quarter ending 2019-06-30 was 107.47K shares.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, shares, employee stock purchase plans for the quarter ending 2019-03-31 was 0.00 shares.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, shares, employee stock purchase plans for the quarter ending 2018-09-30 was 0.00 shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2019-09-30 | 0.00 shares 10-Q/A · filed 2019-11-04 | |
| 2019-06-30 | 107.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-04-29 | |
| 2018-09-30 | 0.00 shares 10-Q · filed 2018-10-26 | |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-04-27 | |
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-10-31 | |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-04 | |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-02 | |
| 2015-09-30 | 0.00 shares 10-Q · filed 2015-11-02 | |
| 2011-09-30 | 326.00K shares 10-Q · filed 2011-10-31 | |
| 2011-06-30 | 272.00K shares 10-Q · filed 2011-08-01 | |
| 2010-09-30 | 0.00 shares 10-Q · filed 2011-10-31 | |
| 2010-06-30 | 530.00K shares 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |